|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PMC |
7281378 |
A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Populatio |
114 KB |
2020-09-27 |
|
17 |
|
2,523 |
2021-04-26
|
| PMC |
7652766 |
A 21st Century Evil: Immunopathology and New Therapies of COVID-19
Abstract
Coronavirus Disease 201 |
118 KB |
2021-01-18 |
|
9 |
|
2,211 |
2021-04-26
|
| PMC |
7712180 |
Host Receptors of Influenza Viruses and Coronaviruses—Molecular Mechanisms of Recognition
Abstract
|
117 KB |
2021-01-18 |
|
9 |
|
2,041 |
2021-04-26
|
| PMC |
7736111 |
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
Abstract
Hyperactivati |
151 KB |
2021-01-18 |
|
9 |
|
1,985 |
2021-04-26
|
| PMC |
7408073 |
The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibit |
112 KB |
2020-09-27 |
|
18 |
|
1,891 |
2021-04-26
|
| PMC |
7200337 |
Immunology of COVID-19: Current State of the Science
Abstract
The coronavirus disease 2019 (COVID-1 |
115 KB |
2020-09-27 |
|
20 |
|
1,863 |
2021-04-26
|
| PMC |
7405836 |
Coronavirus Disease 2019–COVID-19
COVID-19
Dhama et al.
In recent decades, several new diseases hav |
147 KB |
2020-09-27 |
|
17 |
|
1,836 |
2021-04-26
|
| PMC |
7696151 |
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A |
122 KB |
2021-01-18 |
|
8 |
|
1,741 |
2021-04-26
|
| PMC |
7532482 |
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumoni |
65.1 KB |
2020-11-19 |
|
17 |
|
1,724 |
2021-04-26
|
| PMC |
7534795 |
Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associat |
121 KB |
2020-11-19 |
|
18 |
|
1,708 |
2021-04-26
|
